Sphera Management Technology Funds’s Cellebrite CLBT Stock Holding History
Bought
Maintained
Sold
Other funds holding CLBT
TWCM
VC
PP
PF
NTCM
CI
Sphera Management Technology Funds's CLBT Position: Q2 2026 in Review
Sphera Management Technology Funds increased its Cellebrite (CLBT) stake by 37% in Q2 2026, buying an estimated $751K and bringing the position to 211,800 shares worth $3.09M. The position accounts for 1.08% of the portfolio, ranked #31.
Sphera Management Technology Funds first reported a position in CLBT in Q4 2024 and has held it in 6 quarters since. The position peaked at $3.15M in Q3 2025. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.
- Sphera Management Technology Funds held 211,800 shares of Cellebrite worth $3.09M as of Q2 2026.
- Sphera Management Technology Funds bought 56,850 Cellebrite shares in Q2 2026, an estimated $751K.
- Cellebrite made up 1.08% of Sphera Management Technology Funds's portfolio in Q2 2026, its #31 holding.
- Sphera Management Technology Funds first reported a position in Cellebrite in Q4 2024 and has held it in 6 quarters since.
- Sphera Management Technology Funds's Cellebrite position peaked at $3.15M in Q3 2025.
- 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.
Based on Sphera Management Technology Funds's 13F filing for Q2 2026, filed 14 Aug 2026.